|
1
|
Frazier Life Sciences Management
Palo Alto,
California
|
$207M
|
–
|
–
|
–
|
|
|
2
|
Medicxi Ventures Management
St. Helier,
Jersey
|
$124M
|
–
|
–
|
–
|
|
|
3
|
|
$65M
|
+$792K
|
+55,475
|
+1%
|
|
|
4
|
|
$59M
|
+$2.19M
|
+153,224
|
+5%
|
|
|
5
|
Carlyle Group
Washington,
District of Columbia
|
$58M
|
–
|
–
|
–
|
|
|
6
|
Vanguard Group
Malvern,
Pennsylvania
|
$52.7M
|
-$548K
|
-38,361
|
-1%
|
|
|
7
|
Ensign Peak Advisors
Salt Lake City,
Utah
|
$39M
|
-$2.16M
|
-151,324
|
-6%
|
|
|
8
|
Millennium Management
New York
|
$34.5M
|
-$42.8M
|
-2,999,271
|
-59%
|
|
|
9
|
NEA Management Company
Timonium,
Maryland
|
$32.5M
|
–
|
–
|
–
|
|
|
10
|
683 Capital Management
New York
|
$29.6M
|
-$505K
|
-35,380
|
-2%
|
|
|
11
|
Catalys Pacific
Tokyo,
Japan
|
$23.7M
|
+$3.74M
|
+261,900
|
+22%
|
|
|
12
|
Wasatch Advisors
Salt Lake City,
Utah
|
$22.1M
|
-$2.94M
|
-205,549
|
-13%
|
|
|
13
|
GW&K Investment Management
Boston,
Massachusetts
|
$21.7M
|
+$2.32M
|
+162,348
|
+14%
|
|
|
14
|
State Street
Boston,
Massachusetts
|
$19.1M
|
+$1.37M
|
+95,945
|
+9%
|
|
|
15
|
Geode Capital Management
Boston,
Massachusetts
|
$17.8M
|
-$221K
|
-15,476
|
-1%
|
|
|
16
|
Propel Bio Management
Los Angeles,
California
|
$12.3M
|
+$2.68M
|
+187,991
|
+34%
|
|
|
17
|
Catalio Capital Management
New York
|
$11.6M
|
-$6.13M
|
-429,525
|
-38%
|
|
|
18
|
Divisadero Street Capital Management
Miami,
Florida
|
$11M
|
+$9.46M
|
+662,312
|
New
|
|
|
19
|
Moore Capital Management
New York
|
$9.95M
|
–
|
–
|
–
|
|
|
20
|
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$9.11M
|
+$5.64M
|
+394,894
|
+256%
|
|
|
21
|
SummitTX Capital
Fort Worth,
Texas
|
$8.59M
|
+$1.88M
|
+131,852
|
+34%
|
|
|
22
|
Charles Schwab
San Francisco,
California
|
$6.6M
|
+$457K
|
+32,006
|
+9%
|
|
|
23
|
Next Century Growth Investors
Plymouth,
Minnesota
|
$6.53M
|
+$5.62M
|
+393,774
|
New
|
|
|
24
|
|
$6.5M
|
+$3.43M
|
+240,013
|
+158%
|
|
|
25
|
|
$6.38M
|
+$3.96M
|
+277,508
|
+259%
|
|
